Amerisafe, Inc. (NASDAQ:AMSF) Declares Dividend of $3.50

Share on StockTwits

Amerisafe, Inc. (NASDAQ:AMSF) announced a dividend on Tuesday, October 29th, Fidelity reports. Stockholders of record on Wednesday, November 13th will be paid a dividend of 3.50 per share by the insurance provider on Wednesday, November 20th. The ex-dividend date is Tuesday, November 12th.

Shares of Amerisafe stock opened at $70.12 on Friday. The firm has a market cap of $1.36 billion, a PE ratio of 18.17 and a beta of 0.44. The stock has a fifty day moving average price of $65.94 and a 200-day moving average price of $64.19. Amerisafe has a 1 year low of $50.46 and a 1 year high of $71.99.

Amerisafe (NASDAQ:AMSF) last issued its quarterly earnings results on Thursday, October 31st. The insurance provider reported $1.09 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $0.77 by $0.32. The firm had revenue of $91.13 million during the quarter, compared to the consensus estimate of $90.48 million. Amerisafe had a return on equity of 17.50% and a net margin of 20.77%. As a group, equities analysts forecast that Amerisafe will post 3.6 EPS for the current fiscal year.

A number of analysts have recently issued reports on the company. B. Riley set a $75.00 price target on Amerisafe and gave the company a “buy” rating in a research report on Friday, November 1st. BidaskClub upgraded Amerisafe from a “sell” rating to a “hold” rating in a research report on Friday, October 25th. Finally, ValuEngine downgraded Amerisafe from a “buy” rating to a “hold” rating in a research report on Monday, November 4th. Four investment analysts have rated the stock with a hold rating and one has assigned a buy rating to the stock. The stock currently has an average rating of “Hold” and an average target price of $73.00.

In related news, CFO Neal Andrew Fuller sold 2,872 shares of the business’s stock in a transaction that occurred on Monday, September 16th. The stock was sold at an average price of $66.30, for a total value of $190,413.60. Following the completion of the sale, the chief financial officer now owns 18,353 shares in the company, valued at approximately $1,216,803.90. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, Director Randy Roach sold 500 shares of the business’s stock in a transaction that occurred on Tuesday, November 5th. The stock was sold at an average price of $70.05, for a total value of $35,025.00. Following the completion of the sale, the director now owns 8,737 shares of the company’s stock, valued at approximately $612,026.85. The disclosure for this sale can be found here. Insiders sold a total of 4,997 shares of company stock valued at $339,221 in the last 90 days. 1.70% of the stock is currently owned by corporate insiders.

Amerisafe Company Profile

AMERISAFE, Inc, an insurance holding company, underwrites workers' compensation insurance in the United States. Its workers' compensation insurance policies provide benefits to injured employees for temporary or permanent disability, death, and medical and hospital expenses. The company provides workers' compensation insurance for small to mid-sized employers engaged in hazardous industries, principally construction, trucking, logging and lumber, manufacturing, agriculture, maritime, and oil and gas.

Recommended Story: When is a capital gain realized?

Dividend History for Amerisafe (NASDAQ:AMSF)

Receive News & Ratings for Amerisafe Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amerisafe and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

Rhumbline Advisers Boosts Holdings in Barnes & Noble Education Inc
Rhumbline Advisers Boosts Holdings in Barnes & Noble Education Inc
Limoneira  Shares Bought by Rhumbline Advisers
Limoneira Shares Bought by Rhumbline Advisers
Morgan Stanley Has $25,000 Stock Holdings in First Choice Bancorp
Morgan Stanley Has $25,000 Stock Holdings in First Choice Bancorp
Morgan Stanley Has $27,000 Holdings in SMTC Co.
Morgan Stanley Has $27,000 Holdings in SMTC Co.
Morgan Stanley Sells 1,693 Shares of Crinetics Pharmaceuticals Inc
Morgan Stanley Sells 1,693 Shares of Crinetics Pharmaceuticals Inc
Celldex Therapeutics, Inc.  Shares Purchased by Morgan Stanley
Celldex Therapeutics, Inc. Shares Purchased by Morgan Stanley


© 2006-2019 Ticker Report